Fennec Pharmaceuticals FENC Earnings Call Transcripts

NASDAQ FENC
$10.64 +0.06 (+0.57%)
At close: Nov 11, 2026 · 4:00 PM EST
2 earnings calls on file for Fennec Pharmaceuticals, from Q2 2025 to Q1 2026. Each transcript opens in a new tab.
Latest earnings call

Fennec Pharmaceuticals Q1 2026 Earnings Call

May 14, 2026 5,649 words · 25 min read
  • Jeffrey HackmanChief Executive Officer & Board Member
  • Robert AndradeChief Financial Officer
  • Terry EvansChief Commercial Officer
  • Dr. Pierre SayadChief Medical Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Fennec Pharmaceuticals Earnings Call Transcripts

Calls2
LatestMay 14, 2026
SinceQ2 2025

Fiscal 2026

Fiscal 2025

All 2 Fennec Pharmaceuticals transcripts Register to get access to Fennec Pharmaceuticals’s earnings call transcripts.